Is Regeneron Pharmaceuticals, Inc. (REGN) The Most Profitable Biotech Stock To Buy Right Now?

Is Regeneron Pharmaceuticals, Inc. (REGN) The Most Profitable Biotech Stock To Buy Right Now?
The biotech industry is experiencing growth with advancements in AI-driven drug discovery, personalized medicine, and biologics. The global market is set to grow significantly in 2025, driven by innovative breakthroughs and changing market dynamics.